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EFFECT OF CHRONIC TREATMENT WITH A CYCLOOXYGENASE
INHIBITOR ON REPRODUCTIVE PARAMETERS IN MALE RAT
Sheikh A. Saeed, Naheed Anwar, Khalid M. Khan, Noorjehan Sarfraz
Department of Biological & Biomedical Sciences, Aga Khan University, Karachi, Pakistan

Background: Indomethacin is a member of non-steroidal anti-inflammatory drugs (NSAIDs)
commonly used for treatment of gout, arthritis, and other inflammatory conditions. It has been shown to
inhibit ovarian prostaglandins synthesis in mammals, birds, fish and reptiles. However, the effects of its
chronic administration on male reproductive functions remain largely unknown. Using rat as a model,
we studied the effect of chronic treatment with indomethacin on the male reproductive system.
Methods: Testosterone was measured in the serum, testicular tissue, and testicular interstitial fluid by
radioimmunoassay. Moreover, we also studied the direct effect of indomethacin in vitro on luteinizing
hormone stimulated testosterone secretion from the Leydig cells isolated from various treatment
groups. Results: Indomethacin treatment for 50 days caused a significant but reversible decrease in
prostate weight, epididymal sperm reserves and sperm motility score compared with control rats
(p<0.05). In vitro stimulation of Leydig cells isolated from treated rat’s testes with luteinizing hormone
(250 µIU) produced significantly reduced testosterone compared with cells from control groups
(p<0.05). Furthermore, stimulatory effect of luteinizing hormone on the control Leydig cells was
significantly reduced when these cells were challenged with luteinizing hormone in the presence of
indomethacin, (p<0.05). Testosterone concentration in the testicular tissue and testicular interstitial fluid
reduced after indomethacin treatment (p<0.05). Conclusion: Due to its significant inhibition of key
reproductive hormones, indomethacin effectively inhibits reproductive functions if used on a long-term
basis. In his study, we have identified potential risks in the long-term use of cyclooxygenase inhibitors.
Keywords: Cyclooxygenase inhibitor, reproductive functions, male rats

INTRODUCTION
Prostaglandins (PG) play substantial roles in regulating
reproductive activity in both male and females.1,2
Prostaglandins are abundantly found in the male
reproductive tract.3 Prostaglandins E and F play an
important role in sperm metabolism and its functions4,5,
and also increase the contractility of the epididymal
tubule smooth muscle layer6. Moreover, systemic
administration of PGs increases circulating levels of
Prolactin (PRL)7,8, Follicle Stimulating Hormone
(FSH)7 and Luteinizing Hormone ( LH),9,10
It is clear that, chemical inhibition of the PGs
have dramatic effect on female reproduction.11
Indomethacin has been shown to inhibit ovarian
prostaglandins synthesis in mammals12, birds13, fish14,
and reptiles15. Inhibition of PG biosynthesis by
treatment with indomethacin or other NSAIDs during
pro-oestrus, estrus and metestrus phases, prevents
ovulation in rats16 In vitro and in vivo treatment with
indomethacin has shown inhibitory effect on basal and
GDF-9-stimulated progesterone in pre-ovulatory
Granulosa cell culture system.17 Moreover, if
administered at the time of implantation in rabbits
indomethacin
decreases
plasma
progesterone
concentration and the number of viable embryos.18
Prolonged treatment with indomethacin also reduces
fertility in female animals.19 We have demonstrated
previously20 that chronic treatment of male rats with
indomethacin effectively inhibits steroidogenesis at the
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level of testis, which leads to rise in plasma luteinizing
hormone (LH).
Indomethacin,
a
non-steroidal
antiinflammatory drug (NSAIDs), inhibits both isoezymes,
COX1 and COX2.21,22 Inhibition of COX-1 may result
in adverse effects on the gastro-intestinal tract and the
renal functions. COX-2 inhibition leads to antiinflammatory effect23 Indomethacin is prescribed for
alleviation of pain, tenderness, inflammation, and
stiffness caused by gout, arthritis, and other
inflammatory conditions.17 Despite its well-known role
as a PG inhibitor, indomethacin is used for the longterm treatment of several inflammatory conditions, the
effects of its chronic administration on male
reproductive functions remains largely unknown. In this
study, we have investigated the effect of chronic
treatment
with
a
cyclooxygenase
inhibitor
(indomethacin) on reproductive functions. Moreover,
we looked at direct in vitro effects of indomethacin on
LH stimulated testosterone secretion from Leydig cells.

MATERIAL & METHODS
Twenty adult virgin male rats (Wistar, average weight
171±23 g) about 90 days old were randomly allocated to
two groups of 10 each. These rats were obtained from
AKU animal facility where they were maintained under
standard conditions of 14 hr light and 10 hr dark cycle at
23 ºC. The rats had free access to food and water.
Ten rats received daily subcutaneous injections
of indomethacin suspension (Sigma Chemical Co., St
Louis, MO, USA) at a dose of 2 mg/Kg body weight in
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200µl saline for 50 days. This dose was selected after
preliminary tests with different doses. Control (n=10)
received the same volume of saline. Treatment plan is
given in the figure-1. At the end of the treatment rats
were euthanised. Blood, was collected and accessory
reproductive organs (testes, prostate, seminal vesicle,
and epididymes) were dissected, removed and weighed.
A small piece of testes was cut and fixed in 5%
gluteraldehyde for histological studies.
Days

0

100

50
C1
C2

Control

T1
T2
Treated
Indomethacin ON

Indomethacin OFF

Figure-1: Treatment Plan
Leydig cell isolation was carried our according
to the procedure described previously20 Cell viability
(>80% viable) was determined by counting number of
cells excluding trypan blue on a haemocytometer.24
The Leydig cells from each rat in all groups
were incubated with LH and indomethacin, alone or in
combination (no stimulation, LH 250 µg or
LH250+indo 40 µg). LH dilutions were made in the
incubation medium and indomethacin was dissolved in
the organic solvent dimethylsulfoxide (DMSO, Sigma,
2 mg/ml). LH (NIDDK-hLH-B-SIAFP2) was a gift
from National Hormone and Pituitary Programme
California, USA (potency 6100 IU/mg in terms of
WHO IRP 68/40).
TIF was collected as previously described with
some modifications.25–28 Briefly, one testis was used to
collect TIF and it was given small 2 to 4 mm incisions at
the caudal ends of the testes capsules. The testis was
suspended 1 cm above 20 µl of 0.1 M acetic acid in
glass tubes overnight (18–20 hr) at 4 ºC. The TIF
volumes were then carefully measured and stored at -70
ºC till testosterone was measured in them by
radioimmunoassay.
One epididymis from each rat was removed to
determination the epididymal sperm reserve by a
technique modified from.29 Each epididymis was
homogenized using a tissue homogeniser as described
by.30 Homogenate was diluted 1:1 and the epididymal
sperm reserve was calculated by using a
haemocytometer.
Sperm motility score was determined through
a technique described by.30 Sperm samples from the
contralateral vas deferens were used for epididymal
sperm reserve assessment. Each sample was diluted in

0.5 ml of M-199 (Sigma) at 37 ºC for 10 min, and the
percentage of motile sperm and the degree of their
motility (expressed in percent) were determined by
phase contrast microscopy.
Testosterone was measured in the incubation
medium directly by a highly sensitive RIA according to
WHO protocol, using 3H labelled testosterone, as tracer
and a highly specific antiserum for testosterone from
Guildhay UK. Serum and testicular testosterone was
measured in extracted samples, whereas RIA reagents
were directly added to tubes containing incubation
medium. After addition of all the reagents, tubes were
incubated for 30 min. at 4 ºC. The bound and unbound
fractions were separated by the addition of 0.1%
charcoal. Radioactivity was measured in a liquid
scintillation counter.. Testosterone concentration was
calculated by logit-log transformation.31
The sensitivity of testosterone assay was
0.0125 ηg and the intra-assay coefficient of variation
was <10%. The levels of testosterone in the media were
expressed as ηg/ml.
Testicular tissue was prepared for histology by
epoxy resin sectioning. Briefly, a small piece of testes
was fixed in 100 mM cold gluteraldehyde and
cacodylate buffer pH 7.2. Ascending grades of acetone
were used to dehydrate the tissue. Tissue was infiltrated
by the mixtures of acetone and ACM mixture and
embedding was done in ACM II mixture. One micron
thick sections were cut in Nova Ultra tome and stained
with 1% toluidene blue in 1% borax.
All The data obtained were expressed as
Mean±SD. The data was analysed for differences
among treatment and from its withdrawal, using
Student’s t-test. A ‘p-value’ of 0.05 or less was
considered significant.

RESULTS
Table-1 shows the body weights and the various
reproductive parameters. There was a no significant
difference in the body weight between CI and TI.
Indomethacin treated rats did not show any significant
effect on testicular and relative weight of seminal
vesicles but this treatment significantly reduced relative
prostrate weight, compared to their respective control. In
the recovery group, there was a significant difference
(p<0.05) between body weights of control CII and its
respective treated group TII. In these groups, there was
a significant difference (p<0.05) between the testicular
weights and in the weights of seminal vesicles.
Conversely, no significant difference was
noted between weights of the pituitaries in either
treatment or the reversal groups compared with their
respective controls.
Relative epididymal weights in the reversal
group treated animals, TII were significantly (p<0.05)
different compared with their controls, CII. Treatment
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with indomethacin and its termination, significantly
(p<0.05) altered the epididymal sperm reserves
compared to their respective controls.
The mean sperm motility score of male rats
administered indomethacin for 50 days decreased
significantly (p<0.01) compared with the control
animals. Reversal group, TII showed significant
(p<0.01) restorative effect on mean sperm motility
score, compared with TI. However, this score was still
significantly lower (p<0.01) compared with the
respective control group CII.
Results of the in vitro stimulation of Leydig
cells from control animals and treated rats are given in
the Table-2. In vitro stimulation of Leydig cells from
control animals, with LH 250 µIU resulted in
significantly higher (p<0.05) testosterone secretion
compared with control un-stimulated cells from control
animals. Stimulation of Leydig cells from indomethacin
treated animals, with 250 µIU LH produced
significantly (p<0.05) less testosterone as compared
with its control group. In order to investigate effect of
short-term in vitro treatment of Leydig cells with
indomethacin on testosterone secretion, Leydig cells
from the control and the treated rats were stimulated
with LH 250 µIU with or without indomethacin 40 µg.

Treatment with indomethacin significantly
(p<0.05) reduced testosterone secretion in response to
stimulation with LH 250 µIU. However, when Leydig
cells from indomethacin treated rats were stimulated
with LH 250 µIU, their steroidogenic response was
significantly (p<0.05) reduced compared with LH
stimulated Leydig cells from the control animals. In the
group TII, in vitro treatment with LH 250 µIU showed
a significant (p<0.05) stimulatory effect compared with
control. Although statistically at a non-significant level,
LH 250 stimulated increase in the secretion of
testosterone was inhibited both in TI and TII groups by
indomethacin treatment in vitro.
Table-3 shows the concentration of
testosterone in testicular tissue, TIF and serum. The
testicular tissue testosterone concentration significantly
decreased (p<0.05) in the treated group compared with
control. Similarly, TIF testosterone concentration in
indomethacin treated animals was significantly lower
(p<0.05) compared with controls. Testosterone
concentration in testicular interstitial fluid in TII group
was significantly higher (p<0.05) compared with the
treated animals. Serum testosterone in the treated group
was significantly lower (p<0.05) compared with control.
However, there were no significant differences in serum
testosterone levels between CII and TII or TI and TII.

Table-1: Effect of Chronic Treatment With Indomethacin on Some Reproductive Parameters in the Male Rat
Relative
Relative
Relative Seminal
Relative
Relative
Epididymal
Sperm
Treatment
Body
Testes wt.
Prostate wt.
vesicle wt.
Epididymis wt. Pituitary wt.
Sperm
Motility
(n =5)
Weight (g) (g/100g of b.w) (g/100g of b.w) (g/100g of b.w) (g/100g of b.w) (g/100g of b.w) Reserve 10-6
Score
370±50
0.42±0.02
0.19±0.01
0.1±0.01
0.13±0.01
2.0±0.2
5.3±0.55
1730±180
CI
374±32
0.47±0.02
0.15±0.01*
0.1±0
0.13±0
2.2±0.16
3.8±1.1*
465±60*
TI
436±12‡
0.35±0.02‡
0.18±0.04
0.07±0‡
0.11±0‡
1.8±0.2
7.3±0.7
1860±147
CII
334±44†
0.42±0.05†
0.18±0.05
0.1±0.0†
0.15±0.01†§
2.0±0.3
9.2±1.1†§ 1109±199†§
TII
*Significant difference between CI & TI, †Significant difference between CII & TII, ‡Significant difference between CI & CII, §Significant
difference between TI & TII. Key: CI (Saline treated), TI (Indomethacin treated), CII (Saline discontinued), TII (indomethacin discontinued)

Table-2: Effect of Indomethacin on LH Stimulated Testosterone secretion from the Leydig Cells
In vitro Treatment
Treatment (n=3 )
Control
LH 250 µIU
Indo. 40 µg
LH 250 ± Indo. 40

Control I
1.39±0.6
2.6±0.5*
1.1±0.4
1.3±0.7‡

In vivo Treatment
TI
Control II
0.8±0.3
1.2±0.5
1.1±0.2*†
1.8±0.8
0.8±0.3
1.2±0.5
0.9±0.3
1.5±0.6

TII
0.7±0.1
1.1±0.2*
0.6±0.3
0.8±0.3

* Significant differences between Control & LH 250, †Significant difference between LH 250 in control I TI, ‡Significant difference between LH
250 & LH 250+Indo.40

Table-3: Testosterone Concentration in Serum, Testicular Tissue and Testicular Interstitial Fluid
Treatment
Testes-T (ηg/100 mg)
TIF –T (ηg/ml)
Serum-T (ηg/ml)
114±33
105.7±33
5.1±1.5
CI
51±14*
51±14.6*
3.7±0.8*
TI
140±35
112.3±34.6
4.7±1.7
CII
101±33†‡
92.1±23†
3.4±2
TII
*Significant differences between CI & TI, †Significant differences between TI & TII, ‡Significant differences between CII & TII
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Figure-2 shows the transverse section of
seminiferous tubule from a control rat. Note the
presence of a single layer of myoepithelial cells (MC).
Germinal epithelium is arranged compactly and
vesicular nuclei exhibit DNA synthetic activity.
Spermatogonia with dark nuclei (Sg) are present along
the basement membrane. Primary spermatocytes (PS)
show typical condensation of chromosomes depicting
meiotic activity. Toward the lumen spermatids and
sperms (Sp) are in various stages of development.

Figure-4: Reversal Group

DISCUSSION

Figure-2: Control
Figure-3 shows the transverse section of
seminiferous tubule after treatment. Note the presence
of a single layer of MC. The organization of the
germinal epithelium (GE) is disrupted. Large spaces
have appeared in between germinal cells and
degenerating cells are prominent. Absence of meiotic
activity indicates the negative effect of treatment on the
cell cycle in the lineage of spermatocytes.

Figure-3: Treatment with Indomethacin for 50 days
The micrograph in Figure-4 shows transverse
section of seminiferous tubule 50 days after termination
of treatment. Note the presence of a single layer of
myoepithelial cells (arrowheads). Spermatogonia (Sg)
and primary spermatocytes exhibit normal nuclear
profiles indicating normal cell cycle activity.
Intercellular spaces in the germinal epithelium are
eliminated and the luminal side of the epithelium shows
maturation of spermatids and sperms.

Data from our study demonstrates that indomethacin
treatment decreases prostate weight, epididymal sperm
reserves and sperm motility score but cessation of
treatment restores the weight of testis, relative weight of
prostate, epididymes and epididymal sperm reserves, as
well as sperm motility score. Epididymal tubule passage
is an important process that leads to the formation of a
correct milieu for sperm maturation and storage.32
Significant difference between the epididymal sperm
reserve in treated and reversal group shows a bounce
back effect of removal of treatment on the
spermatogenesis. The histological evidence discussed
later, also supports these results.
Previous studies20 showed an increase in plasma
LH during treatment. A drop in T levels by a negative
feedback system causes an elevation of LH from
pituitary. This further explains that indomethacin has a
direct effect at the level of testes rather than pituitary.
Sperm maturation is a complex process and
prostaglandins play an important role by regulating
luminal microenvironment. In basal conditions in
addition to the epididymis COX-2 mRNA and protein is
also expressed in a wide range of tissues like the lung,
testis, brain, and prostate under.33,34 More than 90% of
the extra testicular sperms are stored in epididymis.35
Inhibition of the COX pathway may result in disruption
of epididymal microenvironment. Thus, the decrease in
epididymal weight was likely due to a reduction in
epididymal sperm reserves.
Testosterone concentration measured in
testicular tissue and testicular interstitial fluid was
reduced during treatment and recovered during the
withdrawal period to almost pre-treatment levels. The
same pattern was observed in serum testosterone
concentration. Testosterone secretion and TIF formation
are the two fundamental regulatory aspects of normal
testicular function. There is evidence that AA and its
metabolites are involved in testicular functions. It has
been shown that LH is responsible for rapid release of
AA from Leydig cells36 related to concentration of
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membrane receptors of LH-Hcg37. In vitro data from
this study also supports our observation of indomethacin
induced reduction in serum and TIF testosterone
secretion. Leydig cells from control rats stimulated with
LH in the presence and absence of indomethacin
showed significant difference in testosterone production.
Similarly, Leydig cells from Control group and
indomethacin treated rats responded significantly
different to in vitro LH stimulation.
Our histological evidence from testicular
studies further supports this finding. Figure 1 shows the
transverse section of seminiferous tubule from a control
rat. It presents the normal architecture of the testicular
tissue showing a single layer of myoepithelial cells and
germinal epithelium arranged compactly with vesicular
nuclei exhibiting DNA synthetic activity.
Dark
nucleated spermatogonia (Sg) are visible along the
basement membrane and the primary spermatocytes
(PS) show typical condensation of chromosomes
depicting meiotic activity.
Towards the lumen,
spermatids and sperms (Sp) are in various stages of
development. In the indomethacin treated rats, (Figure
2) organization of the germinal epithelium is disrupted.
Large spaces can be seen in between germinal cells and
degenerating cells are prominent. Treatment also led to
a negative effect on the cell cycle in the lineage of
spermatocytes, indicated by the absence of meiotic
activity. This study also shows that the negative effects
of indomethacin treatment are reversible. Figure 3
shows the transverse section of seminiferous tubule 50
days after termination of treatment. One can note a
single layer of myoepithelial cells, and spermatogonia
and primary spermatocytes exhibiting normal nuclear
profiles indicating normal cell cycle activity. The
germinal epithelium is without the intercellular spaces
noted previously in the treated testes and the luminal
side of the epithelium shows maturation of spermatids
and sperms.

reproduction but also open new avenues to look for
possible contraceptives working through inhibition of
cylooxygenase pathways.
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